ArticleMolecular therapy. Oncology2026
Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma.
Joe Kelk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.